Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walgreens Boots Alliance (NQ: WBA )

8.300 +0.060 (+0.73%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Walgreens Boots Alliance

< Previous 1 2 3 4 5 6 7 8 9
...
68 69 Next >
Is Walgreens Boots Alliance Stock a Buy?
Its challenges are formidable, so only certain investors should consider it. 
Via The Motley Fool
Looking for Stock Bargains With Room to Run? Try This.
Investing tips from Bill Mann, The Motley Fool's director of small-cap research. 
Via The Motley Fool
WBA Investors Have Opportunity to Join Walgreens Boots Alliance, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
1 Healthcare Stock to Sell Now and Never Look Back
This company probably won't go bankrupt, but the stock is unlikely to go up. 
Via The Motley Fool
Topics Bankruptcy
Exposures Financial Legal
A Glimpse Into The Expert Outlook On Walgreens Boots Alliance Through 14 Analysts
Via Benzinga
This Is What Whales Are Betting On Walgreens Boots Alliance
Via Benzinga
Why Walgreens Boots Alliance Plunged Today
Major drug companies are increasingly going direct-to-consumer. 
Via The Motley Fool
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Walgreens Boots Alliance, Inc. (WBA)
From The Law Offices of Frank R. Cruz
Via Business Wire
WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Walgreens Boots Alliance Schedules Fourth Quarter and 2024 Fiscal Year-End Earnings Announcement for October 15
From Walgreens Boots Alliance
Via Business Wire
Large-Cap Stocks In Trouble - Sunday, Sept. 8
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps along with their one-year price returns. 
Via Talk Markets
Realty Income: The Bad News Isn't as Bad as It Seems. 3 Things Investors Should Know.
Investors worry that Realty Income has some troubled tenants, but it's not as big a deal as it may appear. 
Via The Motley Fool
WALGREENS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Walgreens Boots Alliance, Inc. - WBA
From Kahn Swick & Foti, LLC
Via Business Wire
Walgreens Unveils New Premium Skin Care Line – Affordable Luxe for Every Budget
From Walgreens
Via Business Wire
Top 3 Defensive Stocks That Could Lead To Your Biggest Gains In September
Via Benzinga
2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
Johnson & Johnson and Altria Group are two prominent dividend stocks, but I wouldn't rely on their payouts. 
Via The Motley Fool
Why Walgreens Boots Alliance Fell Another 22% in August
The retail pharmacy giant faces ever-mounting headwinds. 
Via The Motley Fool
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update
Via Investor Brand Network
Exposures Product Safety
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Walgreens to Participate in TD Cowen’s 9th Annual FutureHealth Conference
From Walgreens
Via Business Wire
Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 3% Dividend Yields
Via Benzinga
Down About 65% in 2024, Is Walgreens Stock a Buy on the Dip?
Shares of the dividend-paying pharmacy chain have been offering a double-digit yield percentage. 
Via The Motley Fool
WALGREENS BOOTS ALLIANCE, INC. (NASDAQ: WBA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Walgreens Boots Alliance, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Large-Cap Stocks In Trouble - Sunday, Sept. 1
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps with their one-year price returns. 
Via Talk Markets
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets. 
Via Benzinga
Topics Stocks
Exposures US Equities
A $14 Trillion Passive Income Investment Opportunity Is Hiding in Plain Sight (and It's Easier to Access Than You Think)
Freestanding commercial real estate is a goldmine of passive income. 
Via The Motley Fool
Should You Buy the 3 Highest-Yielding Dividend Stocks in the S&P 500?
Walgreens, Altria, and Verizon all have high yields, but are they worth buying just for the yield? Probably not. Here's a deeper look at each. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Intel Suspended Its Dividend, and This Stock Could Be the Next One to Halt Its High-Yielding Payout
Is it only a matter of time before Walgreens Boots Alliance suspends its dividend as well? 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
68 69 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.